December 22, 2022
The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) issued a statement on December 21 deploring the breadth of product coverage for next April’s “off-year” drug price revision finalized on the day by a key reimbursement policy panel. The statement...read more